Standard im contiououlsly amazed at the lack of understand by most regarding what LS is. Its an approved in us and euruope and soon the rest off the world,its mere efficable than current treatment, easier to use for docs, much less painful for the patient. Saves more lives, better for docs, safer, less painful.Im only scrathching the surface of LS use, We are looking literally at a global mononopoly on solid tumors of all types that has every single competintve the currunt alternative product. Did they get off to a lousy sales start yes. But thing what kind of sales they will do do as this becomes the global gold standard, Just becaused they buthchered the rollout does not mean that in 24 months that they not producing immense revenues.
Well he is crazy as a sheet house rat....I prefer the more genteel nature of the sub continent of his parents age, although india #$%$, bangla are basically all sheet houses. By the way expect larger multiple buyers to ramp up.. watch and learn.
There are plenty of nefarious schemers in bios let alone navb. They (shorts) were a miilimeter from victory...ie blowing pps under $1 for good. Thankfully we have Dr Goldberg to thank for not only saving us but actually now putting us in a very nice situation. Lymphoseek will be rhe srandadrd of care for melana,breast, and other solid tumors globally within a few years, China, Japan, Australia, south korea brazil....etc all countries with developed health systems. There is nothing better than LS as we all know from MD A. Now we also open up MT therapies ,its like a early bio with 15 trial products.
Big money wants NAVB and will have it. When? at what price? Who knows. this is Wall Street dogsheet flows downhill. In foreign countries where sweat is money, we have cretins post to make a few dollars a day,
Is a creep in Manila worse than his slick haired GS role model worse? Its all liars and creeps. But LS is a huge winner globally over the next few years. That needs no convincing if you can see.